---
title: "HBM Healthcare Investments says Electra Therapeutics IPO raises USD 350 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299591426.md"
description: "HBM Healthcare Investments reported that portfolio company Electra Therapeutics began trading on Nasdaq as ETRA on Sept. 18, 2026. The IPO was priced at USD 15 per share, raising approximately USD 350 million in gross proceeds from the issuance of 23,330,000 new shares. HBM invested a total of USD 30 million across Series C and the IPO, holding a post-IPO stake valued at USD 32.8 million."
datetime: "2026-09-21T04:45:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299591426.md)
  - [en](https://longbridge.com/en/news/299591426.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299591426.md)
generator: "portal-rs"
---

# HBM Healthcare Investments says Electra Therapeutics IPO raises USD 350 million

-   HBM Healthcare Investments reported portfolio company Electra Therapeutics began trading on Nasdaq as ETRA on Sept. 18, 2026. \* Electra priced an upsized IPO at USD 15 per share, issuing 23,330,000 new shares for about USD 350 million gross proceeds. \* HBM invested USD 15 million in Electra’s 2025 Series C financing, then added USD 15 million in the IPO for USD 30 million total. \* Post-IPO stake stands at about 3.9%, valued at USD 32.8 million based on the first-day closing price. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HBM Healthcare Investments AG published the original content used to generate this news brief via EQS News (Ref. ID: corporate\_2401904\_en) on September 21, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [ETRA.US](https://longbridge.com/en/quote/ETRA.US.md)

## Related News & Research

- [OrbiMed Advisors Discloses Investment at Electra Therapeutics with 11.0% Stake](https://longbridge.com/en/news/300167793.md)
- [Electra Therapeutics adopts amended, restated bylaws effective at IPO close](https://longbridge.com/en/news/299678681.md)
- [Microsoft's blazing stock comeback isn't even close to being over, analyst says](https://longbridge.com/en/news/300955443.md)
- [Michael Burry Raises Red Flag on Oracle’s $664B Backlog and AI Spending: ‘The Customer Is Now the Lender’](https://longbridge.com/en/news/300913488.md)
- [ROI-Oil's new problem isn't supply. It's logistics: Bousso](https://longbridge.com/en/news/300903866.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**